Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis
Status:
Completed
Trial end date:
2019-09-17
Target enrollment:
Participant gender:
Summary
The objectives of this study are:
- To evaluate the efficacy of Nyxol (phentolamine mesylate ophthalmic solution 1%) to
expedite the reversal of pharmacologic mydriasis
- To evaluate the safety of Nyxol
- To evaluate the effect of Lumify® to suppress conjunctival hyperemia (redness)
potentially associated with administration of Nyxol